Christopher Cox - 29 Jul 2021 Form 3 Insider Report for RxSight, Inc. (RXST)

Reporting relationship
Director
Issuer ticker
RXST
Reported as of
29 Jul 2021
Net transaction value
$0
Source evidence Original filing metadata and source links for verification. 3 source fields
SEC form
3
Accepted by SEC
29 Jul 2021, 10:50:41 UTC
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Shelley Thunen, as Attorney-in-Fact

Key filing fact

Christopher Cox filed Form 3 for RxSight, Inc. (RXST) on 29 Jul 2021.

Key facts

  • This page summarizes Christopher Cox's Form 3 filing for RxSight, Inc. (RXST).
  • 0 reported transactions and 8 derivative rows are listed below.
  • Accepted by SEC: 29 Jul 2021, 10:50.

Change

  • No earlier filing in this sequence is available for direct comparison.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

RXST holding Derivative

Stock Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
29 Jul 2021
Ownership
Direct
Underlying class
Common Stock
Underlying amount
48,402
Exercise price
$3.93
Footnotes
F1
RXST holding Derivative

Stock Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
29 Jul 2021
Ownership
Direct
Underlying class
Common Stock
Underlying amount
2,420
Exercise price
$18.91
Footnotes
F1
RXST holding Derivative

Stock Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
29 Jul 2021
Ownership
Direct
Underlying class
Common Stock
Underlying amount
2,420
Exercise price
$18.91
Footnotes
F1
RXST holding Derivative

Stock Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
29 Jul 2021
Ownership
Direct
Underlying class
Common Stock
Underlying amount
968
Exercise price
$18.91
Footnotes
F1
RXST holding Derivative

Stock Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
29 Jul 2021
Ownership
Direct
Underlying class
Common Stock
Underlying amount
2,420
Exercise price
$18.91
Footnotes
F1
RXST holding Derivative

Stock Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
29 Jul 2021
Ownership
Direct
Underlying class
Common Stock
Underlying amount
2,420
Exercise price
$23.04
Footnotes
F1
RXST holding Derivative

Stock Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
29 Jul 2021
Ownership
Direct
Underlying class
Common Stock
Underlying amount
2,420
Exercise price
$11.99
Footnotes
F2
RXST holding Derivative

Stock Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
29 Jul 2021
Ownership
Direct
Underlying class
Common Stock
Underlying amount
2,420
Exercise price
$15.60
Footnotes
F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Shares issued pursuant to the Issuer's 2015 Equity Incentive Plan, as amended.

Footnote F2

Shares issued pursuant to the Issuer's 2015 Equity Incentive Plan, as amended (the "2015 Plan). Subject to the Reporting Person continuing to be a Service Provider (as defined 2015 Plan) through each applicable date, one twenty-fourth (1/24th) of the shares subject to the option shall vest each month following the Vesting Commencement Date on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). "Vesting Commencement Date" shall mean July 30, 2020.

Footnote F3

Shares issued pursuant to the Issuer's 2015 Equity Incentive Plan, as amended (the "2015 Plan). Subject to the Reporting Person continuing to be a Service Provider (as defined 2015 Plan) through each applicable date, one twenty-fourth (1/24th) of the shares subject to the option shall vest each month following the Vesting Commencement Date on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). "Vesting Commencement Date" shall mean March 1, 2021.

SEC remarks

Exhibit 24 - Power of Attorney

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .